IE 11 Not Supported

For optimal browsing, we recommend Chrome, Firefox or Safari browsers.

Preparing K-12 and higher education IT leaders for the exponential era

Agentic AI Platform to Personalize Pharmacy Education at CNU

A partnership between California Northstate University and MindHYVE.ai Inc. will integrate agentic AI to tailor coursework and upskill instructors. It’s the latest such initiative from a health science university.

A person in a white doctor's coat with a stethoscope around their neck holding a blue folder in one hand and extending their other arm with their palm facing up. Floating above their palm is al illustration of a human brain in white.
Shutterstock
Pharmacy students at California Northstate University (CNU) in Sacramento County will soon receive personalized instruction and AI training through a new partnership between the CNU College of Pharmacy and AI company MindHYVE.ai Inc.

The collaboration will bring the company’s agentic AI platform, called ArthurAI, into advanced courses. There, it will use existing curriculum to generate adaptive course content designed to meet evolving technology demands in the pharmaceutical industry, according to a recent news release.

ArthurAI develops learner profiles for each student that take knowledge gaps, pace, attention shifts and retention signals into account to create and adjust individual learning paths, according to the product website.

The tool will be deployed in advanced CNU courses, with potential expansion across its medicine, dentistry, psychology and nursing programs, according to the news release.

In addition to student course materials, the agreement will bring ArthurAI corporate tools designed for AI upskilling to faculty and instructional staff. In partnership with the California Institute of Artificial Intelligence, CNU will train teachers via a four-month certificate program, including 360 hours of AI fluency training.

According to the news release, the system is designed to maintain compliance with the federal Family Educational Rights and Privacy Act (FERPA), including transparent audit trails for institutional oversight.

The agreement reflects broader shifts across the pharmaceutical and health-care sectors as AI tools increasingly automate tasks long associated with pharmacists. According to the UK Clinical Pharmacy Association, AI can automate patient reminders, inventory monitoring and medication safety checks, as well as moving pharmaceutical research forward.

For example, Massachusetts Institute of Technology researchers announced in 2025 that they used AI in research discovering new antibiotics.

“The real challenge facing pharmacy education isn't access to information — anyone can look that up. It’s that AI is already doing what we’ve traditionally trained pharmacists to do,” Bill Faruki, founder and CEO of MindHYVE.ai, said in a public statement. “Drug interaction checks, dosing calculations, formulary management — machines handle that now. The industry doesn’t need more pharmacists educated the old way.”

Other health science universities have entered into similar agreements. Covista, a group of five medical education institutions, partnered with Google in 2025 to create an AI credential program for its students. Similarly, the University of Texas Health Science Center at Houston partnered with OpenAI in 2024 to provide a ChatGPT platform compliant with FERPA and the Health Insurance Portability and Accountability Act.

According to the news release, what sets the CNU agreement apart is ArthurAI’s reasoning capacity and health-science focus.

CNU’s initiative expands an existing collaboration with MindHYVE.ai. The organizations are exploring pharmacogenomics applications using ChironAI, the company’s clinical decision-support platform. The school is also constructing a teaching hospital, hoping to create a pipeline linking AI-driven education with AI-assisted clinical decision-making at the point of care.

“Every health sciences institution will face a decision: adapt to AI or fall behind,” Alvin Cheung, CNU president and CEO, said in a public statement.